RELATIONSHIP BETWEEN DNA DAMAGE AND CELLULAR SENESCENCE
RELATIONSHIP BETWEEN DNA DAMAGE AND CELLULAR SENESCENCE
批准号:
2757746
负责人:
LYNN HARRISON
金额:
$6.72万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-09-01 至 2001-02-28
关键词:
DNA damage RNA Retroviridae antisense nucleic acid beta galactosidase cell cycle cell growth regulation cell senescence chimeric proteins connective tissue cells flow cytometry gene expression green fluorescent proteins histones mitochondrial DNA oxidative stress polymerase chain reaction proliferating cell nuclear antigen pyrophosphatase technology /technique development thymidine kinase transfection /expression vector
中文摘要
新的研究者-研究目标:9.基因表达载体:开发和/或使用条件基因表达载体来调节衰老和细胞特异性基因的表达。该项目的目标是开发一种载体,当在原代培养的人类细胞中表达时,将增加细胞衰老的速度。许多研究已经将氧化DNA损伤与衰老过程联系在一起,并提出线粒体DNA的特异性损伤可能是一个关键因素。然而,用氧化剂处理细胞以破坏DNA会导致脂肪和蛋白质氧化。我们正在开发两种反义RNA表达载体来降低线粒体或核dUTPase。在缺乏这种酶的情况下,dUTP被整合到基因组中。使用细菌dUTP酶突变体的研究表明,碱基切除修复途径试图移除dUTP,导致DNA片断和生长抑制。因此,这项工作将建立一个模型系统,在该系统中,损伤是在线粒体或核基因组中产生的,而不会损害脂质或蛋白质。我们假设线粒体DNA损伤将导致线粒体功能障碍,细胞氧化应激增强,原代细胞在培养中的复制寿命缩短。每个反义RNA特异性降低线粒体或核dUTPase的能力将首先通过在双向启动子转化的细胞中瞬时表达RNA与核或线粒体dUTPase-绿色荧光蛋白融合来测试。从细胞中提取的物质将被用来测量融合的表达。在确定了dUTPase下调的效率后,逆转录病毒载体中的反义RNA序列将被转化为逆转录病毒,并用于感染原代人类细胞(人口增加约15倍)。通过感染传递将确保表达载体在细胞群体中以高频率整合到核基因组中。受感染的人群将接受线粒体功能以及核和线粒体DNA碎裂程度的测试。这些细胞将在培养中保持不变,并评估与衰老相关的β-半乳糖苷酶表达和其他与衰老相关的基因表达变化,以及生长速度和细胞周期的变化。这项研究将更好地确定线粒体或核DNA损伤与复制性衰老之间的关系。
英文摘要
New Investigator - Research objectives: 9. Gene expression vectors: Development and/or use of conditional gene expression vectors for the regulation of aging-and cell-specific gene expression. The goal of this project is to develop a vector which when expressed in primary human cultured cells will increase the rate of cellular senescence. Many studies have correlated oxidative DNA damage with the aging process and it has been suggested that damage specifically to mitochondrial DNA may be a key factor. However, treating cells with oxidizing agents to damage DNA results in lipid and protein oxidation. We are developing two antisense RNA expression vectors to decrease either mitochondrial or nuclear dUTPase. In the absence of this enzyme, dUTP is incorporated into the genome. Studies using bacterial dUTPase mutants indicate that the base excision repair pathway attempts to remove the dUTP resulting in DNA fragmentation and inhibition of growth. This work will therefore establish a model system in which damage is specifically produced in either the mitochondrial or nuclear genome without damaging lipids or proteins. We hypothesize that mitochondrial DNA damage will result in mitochondria dysfunction, an enhanced cellular oxidative stress and a decrease in the replicative life span of primary cells in culture. The ability of each antisense RNA to specifically decrease mitochondrial or nuclear dUTPase will be first tested by transiently expressing the RNA in transformed cells from a bi-directional promoter in combination with either a nuclear or mitochondrial dUTPase-green fluorescent protein fusion. Extracts from the cells will be used to measure the expression of the fusion. Having established the efficiency of down-regulation of dUTPase, the sequence of the antisense RNA in a retroviral vector will be converted to retrovirus and used to infect primary human cells (population doubling approximately 15). Delivery by infection will ensure the expression vectors integrate into the nuclear genome at a high frequency in the cell population. The infected population will be tested for mitochondria function and the level of fragmentation of nuclear and mitochondrial DNA. The cells will be maintained in culture and assessed for senescent-associated expression of beta-galactosidase and other senescent-related changes in gene expression, as well as alteration in growth rate and cell cycle. This study will better define the relationship between mitochondrial or nuclear DNA damage and replicative senescence.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hydrogen Sulfide as a Radiosensitizer for Glioblastoma
-
批准号:9813138
-
项目类别:
-
资助金额:$43.57万
-
财政年份:2019
-
负责人:LYNN HARRISON
-
依托单位:
Enhancing radiation and cisplatin HNSCC cell killing by inhibiting mitochondrial
-
批准号:8451263
-
项目类别:
-
资助金额:$14.72万
-
财政年份:2012
-
负责人:LYNN HARRISON
-
依托单位:
Enhancing radiation and cisplatin HNSCC cell killing by inhibiting mitochondrial
-
批准号:8305841
-
项目类别:
-
资助金额:$18.49万
-
财政年份:2012
-
负责人:LYNN HARRISON
-
依托单位:
DNA Repair of Multiply Damaged Sites in Cells
-
批准号:7909221
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2009
-
负责人:LYNN HARRISON
-
依托单位:
DNA REPAIR OF MULTIPLY DAMAGED SITES IN CELLS
-
批准号:6377800
-
项目类别:
-
资助金额:$19.58万
-
财政年份:2000
-
负责人:LYNN HARRISON
-
依托单位:
DNA REPAIR OF MULTIPLY DAMAGED SITES IN CELLS
-
批准号:6633670
-
项目类别:
-
资助金额:$19.58万
-
财政年份:2000
-
负责人:LYNN HARRISON
-
依托单位:
DNA REPAIR OF MULTIPLY DAMAGED SITES IN CELLS
-
批准号:6514437
-
项目类别:
-
资助金额:$19.58万
-
财政年份:2000
-
负责人:LYNN HARRISON
-
依托单位:
DNA REPAIR OF MULTIPLY DAMAGED SITES IN CELLS
-
批准号:6755930
-
项目类别:
-
资助金额:$19.58万
-
财政年份:2000
-
负责人:LYNN HARRISON
-
依托单位:
DNA REPAIR OF MULTIPLY DAMAGED SITES IN CELLS
-
批准号:6088445
-
项目类别:
-
资助金额:$21.83万
-
财政年份:2000
-
负责人:LYNN HARRISON
-
依托单位:
DNA Repair of Multiply Damaged Sites in Cells
-
批准号:7624393
-
项目类别:
-
资助金额:$24.37万
-
财政年份:2000
-
负责人:LYNN HARRISON
-
依托单位:
DNA Repair of Multiply Damaged Sites in Cells
-
批准号:7424966
-
项目类别:
-
资助金额:$24.37万
-
财政年份:2000
-
负责人:LYNN HARRISON
-
依托单位:
DNA Repair of Multiply Damaged Sites in Cells
-
批准号:7842513
-
项目类别:
-
资助金额:$24.37万
-
财政年份:2000
-
负责人:LYNN HARRISON
-
依托单位:
DNA Repair of Multiply Damaged Sites in Cells
-
批准号:7260307
-
项目类别:
-
资助金额:$24.37万
-
财政年份:2000
-
负责人:LYNN HARRISON
-
依托单位:
DNA Repair of Multiply Damaged Sites in Cells
-
批准号:7142012
-
项目类别:
-
资助金额:$21.94万
-
财政年份:2000
-
负责人:LYNN HARRISON
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于合成生物标志物的超多重RNA数字化检测平台用于肿瘤精准诊断和分期评估
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:程子译
-
依托单位:
RNA m6A修饰通过调控FDX1介导的铜死亡参与补阳还五汤抗脑缺血再灌注损伤作用机制的研究
-
批准号:2026JJ81091
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘亮
-
依托单位:
免标记CRISPR-RNA适配体与门逻辑分子诊断新方法研究
-
批准号:2026JJ50010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:应站明
-
依托单位:
RACK1乳酸化调控RNA损伤—核糖体应激通路介导卵巢癌铂耐药的分子机制和干预研究
-
批准号:82673836
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨毕康
-
依托单位:
Dead-box解旋酶DDX23通过调控RNA高级结构促进肝癌细胞恶性生物学行为的分子机制研究
-
批准号:JCZRLH202600588
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于基因编辑技术解析丹酚酸B靶向SAMHD1调控心肌线粒体RNA稳态干预心衰的分子机制研究
-
批准号:JCZRLH202601084
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
RNA 结合蛋白HuR与VEGF-D联合调控舌鳞癌侵袭及转移机制的研究
-
批准号:2026JJ80684
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:龚攀
-
依托单位:
24-脱氢胆固醇还原酶DHCR24作为RNA结合蛋白调控PIM1翻译促进肾透明细胞癌进展的功能机制研究
-
批准号:82606550
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2026
-
负责人:宁昊
-
依托单位:
RNA结合蛋白SORBS2调控AIM2通路介导内皮焦亡促肺动脉高压血管重构的作用与机制研究
-
批准号:2026JJ50099
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘斌
-
依托单位:
X连锁RNA结合基序蛋白通过上调CXCL8分泌诱导巨噬细胞M2型极化促进结直肠癌奥沙利铂耐药
-
批准号:2026JJ80231
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:曹婷
-
依托单位: